# Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II

> **NCT01527448** · NA · COMPLETED · sponsor: **BC Women's Hospital & Health Centre** · enrollment: 26 (actual)

## Conditions studied

- Postpartum Depression

## Interventions

- **DRUG:** Quetiapine XR (seroquel)

## Key facts

- **NCT ID:** NCT01527448
- **Lead sponsor:** BC Women's Hospital & Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527448, "Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT01527448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*